Shilpa Chokshi is the Acting Director & Chief Scientific Officer at the Roger Williams Institute of Hepatology, Foundation for Liver Research and Adjunct Professor of Experimental Hepatology at King’s College London. In these roles, she is responsible for the provision of scientific and academic leadership to deliver a competitive research programme focussed on the discovery and development of novel biomarkers and drug candidates for the treatment of liver diseases and liver cancers.
The translational research strategy she has implemented aims ‘To support fundamental scientific research that brings clinical benefits for patients with liver disorders’. The competitive research portfolio encompasses the common aetio-specific clinical manifestations of liver disease under the heading of ‘Mechanisms of Hepatic Injury and Repair’ with seven interconnected workstreams that are underpinned by a common cross-cutting theme of inflammation and immune dysfunction.